Multiple sclerosis: Relapses and timing of remissions

European Neurology

Volumn 59, Issue 1-2, 2007, Pages 44-48

  Iuliano, Gerardo ^a,b   Napoletano, Rosa ^a   Esposito, Antonio ^a  

^a Ospedali Riuniti di Salerno   (Italy)

^b NONE   (Italy)

Author keywords

Expanded Disability Status Scale; Relapsing remitting multiple sclerosis; Timing of remissions

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CONVALESCENCE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RATING SCALE; RELAPSE; REMISSION; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; CHILD; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RECURRENCE; RETROSPECTIVE STUDIES; SEX FACTORS; TIME FACTORS;

EID: 37249035893     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109260     Document Type: Article

References (12)

1. Achitii, Grimaud J, Confavreux C: Histoire naturelle et facteurs pronostiques de la sclérose en plaques. Med Ther 2001;7:13-16.
2. Confavreux C, Vukusic S, Moreau T, Adeleine P: Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000;343:1430-1438.
3. Confavreux C, Vukusic S, Adeleine P: Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003;126:770-782.
4. Agence Nationale d'Accréditation et d'Evaluation en Santéet Fédération Française de Neurologie: Conférence de consensus: La sclérose en plaques;Paris, Juin 2001.
5. Goodkin DE: Interferon beta therapy for multiple sclerosis. Lancet 1998;352:1486-1487.
6. Goodin DS, Frohman EM, Garmany G, et al: Disease modifying therapies in multiple sclerosis. Report of the therapeutics and technology assessment subcommittee of the American academy of neurology and the MS council for clinical practice guidelines. Washington, Paralyzed Veterans of America, 2002.
7. Weinshenker BG, Bass B, Rice GPA, Noseworthy J, Carriere W, Baskerville J, Ebers GC: The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112:133-146.
8. Kurtzke JF: Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452.
9. Kurtzke J: The disability status scale for multiple sclerosis: apologia pro DSS sua. Neurology 1989;39:291-302.
10. Rio J, Nos C, Tintore M, Borras C, Galan I, Comabella M, Montalban X: Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon B: implications for clinical trials. Ann Neurol 2002;52:400-406.
11. McDonald I, et al: Recommended diagnostic criteria for MS. Ann Neurol 2001;50:121-127.
12. Rudick RA, Cutter G, Reingold S: The multiple sclerosis functional composite: a new clinical outcome measure for multiple sclerosis trials. Mult Scler 2002;5:359-365.